-+ 0.00%
-+ 0.00%
-+ 0.00%

Rein Therapeutics Begins Enrolling Patients In Phase 2 RENEW Trial

Benzinga·07/21/2026 12:05:51
语音播报
  • Global Expansion Complete as Germany Joins Ongoing Study of Inhaled LTI-03 in Idiopathic Pulmonary Fibrosis
    • Company on track to report initial topline data in 2H 2026